AZOLYLBENZAMIDES AND ANALOGUES AND THEIR USE FOR TREATING OSTEOPOROSIS
申请人:SMITHKLINE BEECHAM PLC
公开号:EP1187813A1
公开(公告)日:2002-03-20
US7220769B2
申请人:——
公开号:US7220769B2
公开(公告)日:2007-05-22
[EN] AZOLYLBENZAMIDES AND ANALOGUES AND THEIR USE FOR TREATING OSTEOPOROSIS<br/>[FR] AZOLYLBENZAMIDE ET ANALOGUES ET LEUR UTILISATION POUR TRAITER L'OSTEOPOROSE
申请人:SMITHKLINE BEECHAM PLC
公开号:WO2001000587A1
公开(公告)日:2001-01-04
A compound of formula (I) or a salt thereof, or a solvate thereof, wherein: X represents oxygen, sulphur, or NRb; Y and Z each independently represent nitrogen, CH, CR1 or CR2; A represents an unsubstituted or substituted aryl group or an unsubstituted or substituted heterocyclyl group; Ra represents -C(O)NRsRt; R1 and R2 each independently represents hydrogen or specific substituents; and the use of such a compound in the treatment and/or prophylaxis of diseases associated with over activity of osteoclasts in mammals.
Azolylbenzamides and analogues and their use for treating osteoporosis
申请人:Farina Carlo
公开号:US20050038095A1
公开(公告)日:2005-02-17
A compound of formula (I) or a salt thereof, or a solvate thereof, wherein: X represents oxygen, sulphur, or NR
b
; Y and Z each independently represent nitrogen, CH, CR
1
or CR
2
; A represents an unsubstituted or substituted aryl group or an unsubstituted or substituted heterocyclyl group; R
a
represents —C(O)NR
s
R
t
; R
1
and R
2
each independently represents hydrogen or specific substituents; and the use of such a compound in the treatment and/or prophylaxis of diseases associated with over activity of osteoclasts in mammals.